Sunesis Pharmaceuticals Inc. (SNSS) [Chart - Analysis - News] is scheduled to announce earnings before the market opens on Thursday, May 27th. Looking at the analyst consensus, it appears most traders believe SNSS is going to announce a loss of 9 cents per share.
As you prepare for SNSS's announcement on Thursday, remember that a loss of 9 cents per share has already been priced into the value of the stock. So if earnings come in at that level, we probably won't see much change in the price of the stock---unless the company changes its outlook for the future. It's also important to remember that good earnings don't always lead to higher stock prices.
SNSS has lost 16 cents (17.55 percent) during the past week and is currently trading below its 20-day and 50-day moving averages but above its 200-day moving average.
Investors will also be evaluating other stocks in the Biotechnology industry as SNSS announces its earnings to see if any of the same factors that are influencing SNSS may also come to bear on those stocks.